Trademark: 79202865
Word
HELSINN BUILDING QUALITY CANCER CARE TOGETHER
Status
Registered
Status Code
700
Status Date
Tuesday, January 9, 2018
Serial Number
79202865
Registration Number
5372161
Registration Date
Tuesday, January 9, 2018
Mark Type
3000
Filing Date
Monday, October 3, 2016
Published for Opposition
Tuesday, October 24, 2017

Trademark Owner History
Helsinn Healthcare SA - Original Registrant

Classifications
40 Treatment in the nature of chemical processing of chemical, biochemical and pharmaceutical products for third parties; consulting services relating to the treatment of chemical, biochemical and pharmaceutical products; information and advisory services in the field of chemical, biochemical and pharmaceutical products treatment and processing
5 Pharmaceutical products, namely, anti-inflammatory drugs, antiemetic drugs, drugs for the treatment of cancer, carcinoma, leukemia, lymphoma, melanoma, anti-tumor drugs, anti-emetic, anti-tumor and anticancer pharmaceutical preparations for the treatment of oncological diseases and the side effects of treatment; drugs for use in case of ulcerative and inflammatory conditions, anti-anxiety drugs, anti-migraine drugs, cognition enhancing drugs, drugs for the prevention and treatment of gastroenterological, hepatologic, nephrologic and cardiovascular disorders of any origin; drugs for internal cleansing purposes, bowel cleansers and evacuants for medical and pharmaceutical purposes, veterinary vaccines and sanitary preparations for medical purposes; dietetic foods adapted for medical use
35 The bringing together, for the benefit of others, of a variety of goods, namely, chemical substances, chemical materials and chemical products, pharmaceutical products, sanitary products for medical purposes, dietetic substances for medical use, excluding the transport thereof, enabling customers and wholesalers to conveniently view and purchase those goods
1 Chemical substances, namely, chemical compounds for analyses in laboratories for scientific purposes, other than for medical or veterinary use
45 Licensing in the field of chemical, biochemical and pharmaceutical products; legal representation and advice, particularly before and during national procedures for the regulation of chemical, biochemical and pharmaceutical products
42 Scientific research and development of pharmaceuticals; scientific and industrial research for the development of drugs and chemical components, as well as technical and scientific consultancy in the fields of scientific research of chemical, biochemical and pharmaceutical technologies; engineering services including engineering surveys in the fields of chemical, biochemical and pharmaceutical technologies; provision of technological professional knowledge, particularly in the field of planning and design of technological development in franchising chemical, biochemical and pharmaceutical products
The mark consists of four squares forming a stylized letter "H" in blue next to and to the left of the word "HELSINN" appearing in gray. The words "BUILDING QUALITY CANCER CARE TOGETHER" appear in blue below "HELSINN".
The color(s) blue and gray is/are claimed as a feature of the mark. The color white constitutes shading, and is not part of the mark.

Trademark Events
Dec 21, 2023
Teas Section 71 & 15 Received
Jan 9, 2023
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Oct 22, 2021
Teas Change Of Correspondence Received
Oct 22, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 22, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 6, 2018
Final Decision Transaction Processed By Ib
Apr 16, 2018
Generic Madrid Transaction Sent To Ib
Apr 16, 2018
Generic Madrid Transaction Created
Apr 9, 2018
Final Disposition Notice Created, To Be Sent To Ib
Jan 9, 2018
Registered-Principal Register
Oct 24, 2017
Official Gazette Publication Confirmation E-Mailed
Oct 24, 2017
Published For Opposition
Oct 21, 2017
Notification Processed By Ib
Oct 4, 2017
Notification Of Possible Opposition Sent To Ib
Oct 4, 2017
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Oct 4, 2017
Notification Of Notice Of Publication E-Mailed
Sep 18, 2017
Approved For Pub - Principal Register
Sep 18, 2017
Examiner's Amendment Entered
Sep 18, 2017
Notification Of Examiners Amendment E-Mailed
Sep 18, 2017
Examiners Amendment E-Mailed
Sep 18, 2017
Examiners Amendment -Written
Sep 9, 2017
Teas/Email Correspondence Entered
Sep 9, 2017
Correspondence Received In Law Office
Sep 9, 2017
Teas Request For Reconsideration Received
Aug 16, 2017
Final Refusal Mailed
Aug 15, 2017
Final Refusal Written
Jul 26, 2017
Teas/Email Correspondence Entered
Jul 26, 2017
Correspondence Received In Law Office
Jul 20, 2017
Assigned To Lie
Jun 15, 2017
Teas Response To Office Action Received
Apr 8, 2017
Refusal Processed By Ib
Mar 21, 2017
Non-Final Action Mailed - Refusal Sent To Ib
Mar 21, 2017
Refusal Processed By Mpu
Mar 21, 2017
Non-Final Action (Ib Refusal) Prepared For Review
Mar 20, 2017
Non-Final Action Written
Mar 14, 2017
Application Filing Receipt Mailed
Mar 11, 2017
Assigned To Examiner
Mar 10, 2017
New Application Office Supplied Data Entered
Mar 9, 2017
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24